Written question asked by Lord Clement-Jones (Liberal Democrat), in the House of Lords. It was due for an answer on Monday, 14 October 2002. It was answered by Lord Hunt of Kings Heath (Labour) on Monday, 14 October 2002.
Hunt of Kings Heath, Lord
- Question
- Whether it is appropriate that the National Blood Service, as a provider of blood and blood derived products to the National Health Service, should be the only representative of manufacturers on national committees, such as the National Transfusion Committee and Serious Hazards of Transfusion, where policy decisions taken may affect product choice and patient use in the National Health Service. [HL 5768].
Secondary information
- Type
- Written question
- Reference
- 639 c36-7WA; HL 5768
- Session
- 2001-02
- Subjects
- Blood NHS Policy Blood transfusions National Blood Service
Librarians' tools
- Timestamp
- 2013-11-24 23:29:04 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_753729
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_753729
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_753729